$Skyline Medical Inc.(SKLN)$
MINNEAPOLIS, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (SKLN) (“Skyline” or the “Company”), today announced an update on commercial activities for its FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal. The Company sold ten STREAMWAY Systems in 2017, five of which were sold in the fourth fiscal quarter of 2017. A further six STREAMWAY units have been booked for sale in January 2018, and will be shipped to customers during the month.
Skyline's revolutionary, FDA-cleared STREAMWAY System is the first true direct-to-drain fluid disposal system designed specifically for medical applications, such as radiology, endoscopy, arthroscopy, urology and cystoscopy procedures. It connects directly to a facility's plumbing system to automate the collection, measurement and disposal of waste fluids.
精彩评论